IBDEI0NJ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10756,0)
 ;;=D68.32^^68^675^82
 ;;^UTILITY(U,$J,358.3,10756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10756,1,3,0)
 ;;=3^Hemorrhagic Disorder d/t Extrinsic Circulating Anticoagulants
 ;;^UTILITY(U,$J,358.3,10756,1,4,0)
 ;;=4^D68.32
 ;;^UTILITY(U,$J,358.3,10756,2)
 ;;=^5002357
 ;;^UTILITY(U,$J,358.3,10757,0)
 ;;=C22.2^^68^675^83
 ;;^UTILITY(U,$J,358.3,10757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10757,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,10757,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,10757,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,10758,0)
 ;;=D58.9^^68^675^85
 ;;^UTILITY(U,$J,358.3,10758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10758,1,3,0)
 ;;=3^Hereditary Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,10758,1,4,0)
 ;;=4^D58.9
 ;;^UTILITY(U,$J,358.3,10758,2)
 ;;=^5002322
 ;;^UTILITY(U,$J,358.3,10759,0)
 ;;=C81.99^^68^675^86
 ;;^UTILITY(U,$J,358.3,10759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10759,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,10759,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,10759,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,10760,0)
 ;;=C81.90^^68^675^87
 ;;^UTILITY(U,$J,358.3,10760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10760,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,10760,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,10760,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,10761,0)
 ;;=D89.2^^68^675^88
 ;;^UTILITY(U,$J,358.3,10761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10761,1,3,0)
 ;;=3^Hypergammaglobulenemia,Unspec
 ;;^UTILITY(U,$J,358.3,10761,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,10761,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,10762,0)
 ;;=D05.12^^68^675^89
 ;;^UTILITY(U,$J,358.3,10762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10762,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Left Breast
 ;;^UTILITY(U,$J,358.3,10762,1,4,0)
 ;;=4^D05.12
 ;;^UTILITY(U,$J,358.3,10762,2)
 ;;=^5001931
 ;;^UTILITY(U,$J,358.3,10763,0)
 ;;=D05.11^^68^675^90
 ;;^UTILITY(U,$J,358.3,10763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10763,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Right Breast
 ;;^UTILITY(U,$J,358.3,10763,1,4,0)
 ;;=4^D05.11
 ;;^UTILITY(U,$J,358.3,10763,2)
 ;;=^5001930
 ;;^UTILITY(U,$J,358.3,10764,0)
 ;;=D05.10^^68^675^91
 ;;^UTILITY(U,$J,358.3,10764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10764,1,3,0)
 ;;=3^Intraductal Carcinoma in Situ,Unspec Breast
 ;;^UTILITY(U,$J,358.3,10764,1,4,0)
 ;;=4^D05.10
 ;;^UTILITY(U,$J,358.3,10764,2)
 ;;=^5001929
 ;;^UTILITY(U,$J,358.3,10765,0)
 ;;=D50.0^^68^675^92
 ;;^UTILITY(U,$J,358.3,10765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10765,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,10765,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,10765,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,10766,0)
 ;;=D50.9^^68^675^93
 ;;^UTILITY(U,$J,358.3,10766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10766,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,10766,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,10766,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,10767,0)
 ;;=C46.9^^68^675^94
 ;;^UTILITY(U,$J,358.3,10767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10767,1,3,0)
 ;;=3^Kaposi's Sarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,10767,1,4,0)
 ;;=4^C46.9
 ;;^UTILITY(U,$J,358.3,10767,2)
 ;;=^5001108
 ;;^UTILITY(U,$J,358.3,10768,0)
 ;;=C22.0^^68^675^95
 ;;^UTILITY(U,$J,358.3,10768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10768,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,10768,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,10768,2)
 ;;=^5000933
